Disclosures for "Establishing an Association Between the Increasingly Prescribed Glucagon-like Peptide-1 Receptor Agonists and Nonarteritic Anterior Ischemic Optic Neuropathy in Patients with Vascular Risk Factors"
-
Dr. Gandhi has nothing to disclose.
-
Dr. Kaur has nothing to disclose.
-
Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Desai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech.